Paediatric and Geriatric Pharmacotherapy
Paediatric and Geriatric Pharmacotherapy
Pharmacotherapy refers to the use of medications to treat diseases and manage medical conditions. However, the approach to pharmacotherapy can vary significantly across different age groups due to physiological differences, disease prevalence, and drug metabolism. Paediatric and geriatric pharmacotherapy are specialized fields that focus on the unique pharmacological needs of children and older adults, respectively.
Related Conference of Paediatric and Geriatric Pharmacotherapy
September 15-16, 2025
29th International Conference on Neuropharmacology and Neurochemistry
Bangkok, Thailand
September 22-23, 2025
5th International Conference on Biomedicine & Pharmacotherapy
Amsterdam, Netherlands
November 24-25, 2025
7th World Congress on Advanced Clinical Trials and Clinical Research
Barcelona, Spain
November 24-25, 2025
4th International Forum on Pharmacovigilance and Regulatory Affairs
Barcelona, Spain
Paediatric and Geriatric Pharmacotherapy Conference Speakers
Recommended Sessions
- Advanced Drug Delivery Systems
- Advances in Vaccine Technology
- Advances in Omics Technologies
- Artificial Intelligence in Biomedicine
- Biotechnology in Drug Development
- Cardiovascular Pharmacotherapy
- Clinical Pharmacology and Therapeutics
- Digital Health and Telemedicine
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals
- Gene Therapy and Genetic Medicine
- Immunotherapy and Immunopharmacology
- Infectious Diseases and Antimicrobial Resistance
- Innovations in Biologics and Biosimilars
- Metabolic Disorders and Endocrinology
- Nanotechnology in Biomedicine
- Neuropharmacology and Neurotherapeutics
- Oncology Research and Therapeutics
- Paediatric and Geriatric Pharmacotherapy
- Pharmacogenomics and Personalized Medicine
- Pharmacovigilance and Drug Safety
- Public Health and Pharmacoeconomics
- Rare and Orphan Diseases: Therapeutic Approaches
- Rare Disease Therapeutics
- Regenerative Medicine and Tissue Engineering
- Respiratory and Pulmonary Pharmacotherapy
Related Journals
Are you interested in
- Adaptive Trial Models - Clinical Trials Congress 2025 (Spain)
- Advanced Data Analytics - Clinical Trials Congress 2025 (Spain)
- Advanced Drug Delivery Systems - BIOMEDICINE 2025 (Netherlands)
- Advances in Omics Technologies - BIOMEDICINE 2025 (Netherlands)
- Advances in Vaccine Technology - BIOMEDICINE 2025 (Netherlands)
- Adverse Event Reporting through Mobile Health Tools - Euro Pharmacovigilance 2025 (Spain)
- AI in Clinical Research - Clinical Trials Congress 2025 (Spain)
- AI-Driven Signal Detection and Data Mining - Euro Pharmacovigilance 2025 (Spain)
- AI-Powered Pharmacovigilance - Clinical Trials Congress 2025 (Spain)
- Alzheimer’s and Parkinson’s Diseases - Neuropharmaceutics 2025 (Thailand)
- Artificial Intelligence in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Automation in Case Processing and Reporting - Euro Pharmacovigilance 2025 (Spain)
- Biotechnology in Drug Development - BIOMEDICINE 2025 (Netherlands)
- Blockchain Applications - Clinical Trials Congress 2025 (Spain)
- Blockchain Applications in Regulatory Data Integrity - Euro Pharmacovigilance 2025 (Spain)
- Brain Injury and Behavioral Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Brain Pathology and Oncology Research - Neuropharmaceutics 2025 (Thailand)
- Brain Stimulation and Imaging - Neuropharmaceutics 2025 (Thailand)
- Brain Structure and Function - Neuropharmaceutics 2025 (Thailand)
- Cardiovascular Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Clinical Neurophysiology and Stroke - Neuropharmaceutics 2025 (Thailand)
- Clinical Pharmacology and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Clinical Supply Chain Innovation - Clinical Trials Congress 2025 (Spain)
- CNS and Brain Disorders - Neuropharmaceutics 2025 (Thailand)
- Cognitive Neuroscience and Psychology - Neuropharmaceutics 2025 (Thailand)
- Data Integrity & Compliance - Clinical Trials Congress 2025 (Spain)
- Decentralized Trials - Clinical Trials Congress 2025 (Spain)
- Digital Health and Telemedicine - BIOMEDICINE 2025 (Netherlands)
- Digital Therapeutics Trials - Clinical Trials Congress 2025 (Spain)
- Digital Transformation in Drug Safety Operations - Euro Pharmacovigilance 2025 (Spain)
- Diversity in Enrollment - Clinical Trials Congress 2025 (Spain)
- eConsent & Retention Tools - Clinical Trials Congress 2025 (Spain)
- eSource & EDC Systems - Clinical Trials Congress 2025 (Spain)
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals - BIOMEDICINE 2025 (Netherlands)
- Ethics and Legal Challenges in Drug Safety Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Gene Therapy and Genetic Medicine - BIOMEDICINE 2025 (Netherlands)
- Global Harmonization of Regulatory Frameworks - Euro Pharmacovigilance 2025 (Spain)
- Global Regulatory Landscape - Clinical Trials Congress 2025 (Spain)
- Global Signal Management Systems and Standards - Euro Pharmacovigilance 2025 (Spain)
- Human Brain Mapping - Neuropharmaceutics 2025 (Thailand)
- Immunotherapy and Immunopharmacology - BIOMEDICINE 2025 (Netherlands)
- Infectious Diseases and Antimicrobial Resistance - BIOMEDICINE 2025 (Netherlands)
- Innovations in Biologics and Biosimilars - BIOMEDICINE 2025 (Netherlands)
- Inspection Readiness and Audit Best Practices - Euro Pharmacovigilance 2025 (Spain)
- Integration of PV with Quality and Regulatory Affairs - Euro Pharmacovigilance 2025 (Spain)
- Managing Safety Data in Multi-Region Submissions - Euro Pharmacovigilance 2025 (Spain)
- Master Protocol Strategies - Clinical Trials Congress 2025 (Spain)
- Metabolic Disorders and Endocrinology - BIOMEDICINE 2025 (Netherlands)
- Molecular and cellular neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Nanotechnology in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Neurobiology and Behaviors - Neuropharmaceutics 2025 (Thailand)
- Neurogenesis - Neuropharmaceutics 2025 (Thailand)
- Neuroimmunology and Neurological Infections - Neuropharmaceutics 2025 (Thailand)
- Neuroinformatics and Computational Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Neurological Disorders and Stroke - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and genetic aspects of CNS function - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurotherapeutics - BIOMEDICINE 2025 (Netherlands)
- Neurorehabilitation and Neural Repair - Neuropharmaceutics 2025 (Thailand)
- Neuroscience and Artificial Intelligence - Neuropharmaceutics 2025 (Thailand)
- Neurotherapeutics and Case Studies - Neuropharmaceutics 2025 (Thailand)
- Oncology Research and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Paediatric and Geriatric Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Patient-Centric Designs - Clinical Trials Congress 2025 (Spain)
- Patient-Centric Pharmacovigilance Strategies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacogenomics and Personalized Medicine - BIOMEDICINE 2025 (Netherlands)
- Pharmacovigilance and Drug Safety - BIOMEDICINE 2025 (Netherlands)
- Pharmacovigilance Compliance in Clinical Trials - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Accelerated Drug Approvals - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Gene and Cell Therapies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance Outsourcing and Vendor Oversight - Euro Pharmacovigilance 2025 (Spain)
- Pre- and post-synaptic function - Neuropharmaceutics 2025 (Thailand)
- Public Health and Pharmacoeconomics - BIOMEDICINE 2025 (Netherlands)
- Rare and Orphan Diseases: Therapeutic Approaches - BIOMEDICINE 2025 (Netherlands)
- Rare Disease Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Real-World Evidence in Post-Marketing Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Real-World Evidence Integration - Clinical Trials Congress 2025 (Spain)
- Regenerative Medicine and Tissue Engineering - BIOMEDICINE 2025 (Netherlands)
- Respiratory and Pulmonary Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Risk Management Planning and Benefit-Risk Assessment - Euro Pharmacovigilance 2025 (Spain)
- Risk-Based Monitoring - Clinical Trials Congress 2025 (Spain)
- Safety Labeling Changes and Regulatory Communication - Euro Pharmacovigilance 2025 (Spain)
- Safety Monitoring of Biologics and Biosimilars - Euro Pharmacovigilance 2025 (Spain)
- Stem Cells Role in Neuro-Biological Treatment - Neuropharmaceutics 2025 (Thailand)
- Synapse formation and neurotransmitter receptors - Neuropharmaceutics 2025 (Thailand)
- Synaptic Function and Dysfunction in Brain Diseases - Neuropharmaceutics 2025 (Thailand)
- Synaptic plasticity and memory - Neuropharmaceutics 2025 (Thailand)
- Synthetic Control Arms - Clinical Trials Congress 2025 (Spain)
- Virtual Trial Platforms - Clinical Trials Congress 2025 (Spain)
- Wearables & Remote Monitoring - Clinical Trials Congress 2025 (Spain)